Skip to main content
Erschienen in: International Journal of Clinical Pharmacy 5/2015

01.10.2015 | Short Research Report

Benzodiazepine prescribing guideline adherence and misuse potential in Irish minors

verfasst von: Kevin D. Murphy, Laura J. Sahm, Suzanne McCarthy, Stephen Byrne

Erschienen in: International Journal of Clinical Pharmacy | Ausgabe 5/2015

Einloggen, um Zugang zu erhalten

Abstract

Background

The Good Prescribing Practice for Clinicians guidelines were published in 2002 in Ireland to guide General Practitioners about prescribing benzodiazepines. There has been no research to-date to measure compliance by General Practitioners. Inappropriate prescribing to minors may result in increased use or misuse of benzodiazepines.

Objective

The purpose of this study was to evaluate the prescribing of benzodiazepines to minors in Ireland against the Good Prescribing Practice for Clinicians guidelines.

Method

Data for medicines dispensed between January 2009 and December 2012 from the Health Intelligence Ireland database were accessed and analysed. This database contains information about government-subsidised community-pharmacy-dispensed medicines.

Results

Benzodiazepine prescribing to minors increased by 10.2 % between 2009 and 2012. Almost 15 % of patients (n = 2193) were prescribed benzodiazepines for greater than four weeks; which contravenes the guidelines. Approximately half (51.4 %) of prescribers who contravened this guideline, prescribed all their benzodiazepines in quantities of greater than one week, against the recommendations of the guidelines.

Conclusion

The consequences of prescribing against National Guidelines can result in patients who become long-term benzodiazepine users and thus place an increased burden upon the healthcare system. The reasons for non-compliance by GPs should be investigated to find solutions.
Literatur
1.
Zurück zum Zitat Longo L, Johnson B. Addiction: Part I. Benzodiazepines-side effects, abuse risk and alternatives. Am. Fam. Phys. 2000;61(7):2121. Longo L, Johnson B. Addiction: Part I. Benzodiazepines-side effects, abuse risk and alternatives. Am. Fam. Phys. 2000;61(7):2121.
2.
Zurück zum Zitat Carlsten A, Waern M. Are sedatives and hypnotics associated with increased suicide risk of suicide in the elderly? BMC Geriatr. 2009;9(1):20–6.PubMedCentralCrossRefPubMed Carlsten A, Waern M. Are sedatives and hypnotics associated with increased suicide risk of suicide in the elderly? BMC Geriatr. 2009;9(1):20–6.PubMedCentralCrossRefPubMed
3.
Zurück zum Zitat Pae C-U, Koh JS, Lee S-J, Han C, Patkar AA, Masand PS. Association of sedative–hypnotic medications with suicidality. Expert Rev Neurother. 2011;11(3):345–9.CrossRefPubMed Pae C-U, Koh JS, Lee S-J, Han C, Patkar AA, Masand PS. Association of sedative–hypnotic medications with suicidality. Expert Rev Neurother. 2011;11(3):345–9.CrossRefPubMed
4.
Zurück zum Zitat Youssef N, Rich C. Does acute treatment with sedatives/hypnotics for anxiety in depressed patients affect suicide risk? A literature review. Ann. Clin. Psychiatry 2008;20(3):157–69. Youssef N, Rich C. Does acute treatment with sedatives/hypnotics for anxiety in depressed patients affect suicide risk? A literature review. Ann. Clin. Psychiatry 2008;20(3):157–69.
7.
Zurück zum Zitat Smith AJ, Tett SE. How do different age groups use benzodiazepines and antidepressants? Analysis of an Australian administrative database, 2003–2006. Drugs Aging. 2009;26(2):113–22.CrossRefPubMed Smith AJ, Tett SE. How do different age groups use benzodiazepines and antidepressants? Analysis of an Australian administrative database, 2003–2006. Drugs Aging. 2009;26(2):113–22.CrossRefPubMed
8.
Zurück zum Zitat Steffenak AK, Wilde-Larsson B, Nordstrom G, Skurtveit S, Hartz I. Increase in psychotropic drug use between 2006 and 2010 among adolescents in Norway: a nationwide prescription database study. J Clin Epidemiol. 2012;4:225–31.CrossRef Steffenak AK, Wilde-Larsson B, Nordstrom G, Skurtveit S, Hartz I. Increase in psychotropic drug use between 2006 and 2010 among adolescents in Norway: a nationwide prescription database study. J Clin Epidemiol. 2012;4:225–31.CrossRef
9.
Zurück zum Zitat McLean CP, Asnaani A, Litz BT, Hofmann SG. Gender differences in anxiety disorders: prevalence, course of illness, comorbidity and burden of illness. J Psychiatr Res. 2011;45(8):1027–35.PubMedCentralCrossRefPubMed McLean CP, Asnaani A, Litz BT, Hofmann SG. Gender differences in anxiety disorders: prevalence, course of illness, comorbidity and burden of illness. J Psychiatr Res. 2011;45(8):1027–35.PubMedCentralCrossRefPubMed
10.
Zurück zum Zitat Linehan C, Kerr MP, Walsh PN, Brady G, Kelleher C, Delanty N, et al. Examining the prevalence of epilepsy and delivery of epilepsy care in Ireland. Epilepsia. 2010;51(5):845–52.CrossRefPubMed Linehan C, Kerr MP, Walsh PN, Brady G, Kelleher C, Delanty N, et al. Examining the prevalence of epilepsy and delivery of epilepsy care in Ireland. Epilepsia. 2010;51(5):845–52.CrossRefPubMed
Metadaten
Titel
Benzodiazepine prescribing guideline adherence and misuse potential in Irish minors
verfasst von
Kevin D. Murphy
Laura J. Sahm
Suzanne McCarthy
Stephen Byrne
Publikationsdatum
01.10.2015
Verlag
Springer Netherlands
Erschienen in
International Journal of Clinical Pharmacy / Ausgabe 5/2015
Print ISSN: 2210-7703
Elektronische ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-015-0138-8

Weitere Artikel der Ausgabe 5/2015

International Journal of Clinical Pharmacy 5/2015 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.